NO20065873L - 3-(4-(2-dihydroisoksazol-3-ylpyridin-5-yl)fenyl)-5-triazol-1-ylmetyloksoazolidin-2-on derivater som MAO inhibitorer i behandlingen av bakterielle infeksjoner - Google Patents
3-(4-(2-dihydroisoksazol-3-ylpyridin-5-yl)fenyl)-5-triazol-1-ylmetyloksoazolidin-2-on derivater som MAO inhibitorer i behandlingen av bakterielle infeksjonerInfo
- Publication number
- NO20065873L NO20065873L NO20065873A NO20065873A NO20065873L NO 20065873 L NO20065873 L NO 20065873L NO 20065873 A NO20065873 A NO 20065873A NO 20065873 A NO20065873 A NO 20065873A NO 20065873 L NO20065873 L NO 20065873L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- ylmethyloxoazolidin
- ylpyridin
- dihydroisoxazol
- triazol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Cephalosporin Compounds (AREA)
Abstract
Forbindelser med formel I samt farmasøytisk akseptable salter og prodrugs derav er beskrevet, hvor R1, R2, R3 og R4 er som definert heri. Det er også beskrevet fremgangsmåter for fremstilling av forbindelser med formel I samt metoder for anvendelse av forbindelser med formel I for behandling av bakterielle infeksjoner.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0411595A GB0411595D0 (en) | 2004-05-25 | 2004-05-25 | Chemical compounds |
GB0500056A GB0500056D0 (en) | 2005-01-05 | 2005-01-05 | Chemical compounds |
PCT/GB2005/002059 WO2005116024A1 (en) | 2004-05-25 | 2005-05-24 | 3- (4- (2-dihydroisoxazol-3-ylpyridin-5-yl) phenyl) -5-triazol-1-ylmethyloxazolidin-2-one derivaives as mao inhibitors for the treatment of bacterial infections |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20065873L true NO20065873L (no) | 2007-02-20 |
Family
ID=34968728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20065873A NO20065873L (no) | 2004-05-25 | 2006-12-19 | 3-(4-(2-dihydroisoksazol-3-ylpyridin-5-yl)fenyl)-5-triazol-1-ylmetyloksoazolidin-2-on derivater som MAO inhibitorer i behandlingen av bakterielle infeksjoner |
Country Status (10)
Country | Link |
---|---|
US (1) | US20070208062A1 (no) |
EP (1) | EP1753753A1 (no) |
JP (1) | JP2008500319A (no) |
AU (1) | AU2005247671A1 (no) |
BR (1) | BRPI0511535A (no) |
CA (1) | CA2567457A1 (no) |
IL (1) | IL179346A0 (no) |
MX (1) | MXPA06013540A (no) |
NO (1) | NO20065873L (no) |
WO (1) | WO2005116024A1 (no) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100854211B1 (ko) | 2003-12-18 | 2008-08-26 | 동아제약주식회사 | 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물 |
US8314110B2 (en) * | 2007-04-19 | 2012-11-20 | Youxin Li | Compounds for treating mental disorders, and preparation and uses thereof |
KR101023174B1 (ko) * | 2008-09-24 | 2011-03-18 | 주식회사 레고켐 바이오사이언스 | 사이클릭 아미독심 또는 사이클릭 아미드라존 기를 가지는 신규한 옥사졸리디논 유도체 및 이를 함유하는 의약 조성물 |
MX366793B (es) | 2008-10-10 | 2019-07-24 | Merck Sharp & Dohme Corp Star | Metodos para preparar oxazolidinonas y composiciones que las contienen. |
EP2367820B1 (en) | 2008-11-20 | 2016-09-21 | Panacea Biotec Limited | Novel antimicrobial agents |
KR101739923B1 (ko) | 2009-02-03 | 2017-05-25 | 머크 샤프 앤드 돔 코포레이션 | R)-3-(4-(2-(2-메틸테트라졸-5-일)피리딘-5-일)-3-플루오로페닐)-5-히드록시메틸 옥사졸리딘-2-온 디히드로겐 포스페이트의 결정형 |
US8580767B2 (en) * | 2009-05-28 | 2013-11-12 | Trius Therapeutics, Inc. | Oxazolidinone containing dimer compounds, compositions and methods to make and use |
AU2010264027B9 (en) | 2009-06-26 | 2013-06-13 | Panacea Biotec Ltd. | Novel azabicyclohexanes |
CA2772075C (en) * | 2009-09-04 | 2017-02-28 | Rashida A. Karmali | Novel compositions and processes for preparing 5-amino or substituted amino 1,2,3-triazoles and triazole orotate formulations |
KR101653570B1 (ko) * | 2011-03-30 | 2016-09-02 | 주식회사 레고켐 바이오사이언스 | 신규한 옥사졸리디논 유도체 및 이를 함유하는 의약 조성물 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1427711E (pt) * | 2001-09-11 | 2005-11-30 | Astrazeneca Ab | Derivados de oxazolidinona e/ou isoxazolina como agentes antibacterianos |
JP2003335762A (ja) * | 2002-05-20 | 2003-11-28 | Meiji Seika Kaisha Ltd | 新規ビフェニル誘導体 |
CA2507468A1 (en) * | 2002-11-28 | 2004-06-10 | Astrazeneca Ab | Oxazolidinone and / or isoxazoline derivatives as antibacterial agents |
TW200500360A (en) * | 2003-03-01 | 2005-01-01 | Astrazeneca Ab | Hydroxymethyl compounds |
KR100854211B1 (ko) * | 2003-12-18 | 2008-08-26 | 동아제약주식회사 | 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물 |
-
2005
- 2005-05-24 MX MXPA06013540A patent/MXPA06013540A/es not_active Application Discontinuation
- 2005-05-24 WO PCT/GB2005/002059 patent/WO2005116024A1/en not_active Application Discontinuation
- 2005-05-24 CA CA002567457A patent/CA2567457A1/en not_active Abandoned
- 2005-05-24 BR BRPI0511535-3A patent/BRPI0511535A/pt not_active Application Discontinuation
- 2005-05-24 JP JP2007514091A patent/JP2008500319A/ja active Pending
- 2005-05-24 EP EP05746284A patent/EP1753753A1/en not_active Withdrawn
- 2005-05-24 US US11/569,150 patent/US20070208062A1/en not_active Abandoned
- 2005-05-24 AU AU2005247671A patent/AU2005247671A1/en not_active Abandoned
-
2006
- 2006-11-16 IL IL179346A patent/IL179346A0/en unknown
- 2006-12-19 NO NO20065873A patent/NO20065873L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BRPI0511535A (pt) | 2008-01-02 |
MXPA06013540A (es) | 2007-01-26 |
CA2567457A1 (en) | 2005-12-08 |
WO2005116024A1 (en) | 2005-12-08 |
IL179346A0 (en) | 2007-03-08 |
JP2008500319A (ja) | 2008-01-10 |
EP1753753A1 (en) | 2007-02-21 |
AU2005247671A1 (en) | 2005-12-08 |
US20070208062A1 (en) | 2007-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20065873L (no) | 3-(4-(2-dihydroisoksazol-3-ylpyridin-5-yl)fenyl)-5-triazol-1-ylmetyloksoazolidin-2-on derivater som MAO inhibitorer i behandlingen av bakterielle infeksjoner | |
NO20054852L (no) | GFAT inhibitorer | |
NO20065902L (no) | 3-{4-(pyridin-3-yl)fenyl}-5-(1H-,1,2,3-triazol-1-ylmetyl)-1,3-oksazolidin-2-oner som antibakterielle midler | |
NO20075059L (no) | Nye forbindelser II 2-pyridinderivater som inhibitorer av neutrofil elastase | |
NO20044866L (no) | Pyrazolo-pyrimidin-anilin-forbindelser anvendelige som kinase-inhibitorer | |
NO20061454L (no) | Compounds having CRTH2 antagonist activity | |
NO20070458L (no) | Aryl-pyridinderivater som 11-Beta-HSD1 inhibitorer | |
NO20091409L (no) | Pyridin-3-yl-derivater som immunmodulerende midler | |
NO20076066L (no) | Oksadiazolderivater som DGAT-inhibitorer | |
HK1086256A1 (en) | Substituted pyrrolo-pyrazole derivatives as kinase inhibitors | |
NO20060147L (no) | Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav | |
NO20061657L (no) | Pyrolderivater med antibakteriell aktivitet | |
NO20074703L (no) | Antibakterielle piperidinderivater | |
NO20076695L (no) | Nye MCHR1-antagonister og deres anvendelse for behandling av MCHR1-medierte tilstander og forstyrrelser | |
NO20064282L (no) | Morfolinforbindelser | |
SE0401971D0 (sv) | Piperidne derivatives | |
NO20065503L (no) | Indolyderivater som lever-X-resptormodulatorer. | |
NO20083114L (no) | Polysykliske indazolderivater som er ERK-inhibitorer | |
NO20082159L (no) | Triazolopyridinderivater som inhibitorer av lipaser og fosfolipaser | |
NO20060146L (no) | Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav | |
NO20064010L (no) | Indazolderivater og farmasoytiske preparater inneholdelse slike | |
NO20071137L (no) | Nye piperidinderivater for behandling av depresjon | |
NO20044501L (no) | [1,4] diazenino [6,7,1-IJ] kinolin-derivater som antipsykotis og antifedme-midler | |
NO20091590L (no) | Heterocykliske amidforbindelser anvendbare som kinaseinhibitorer | |
NO20063576L (no) | 1,3-dioksanederivativer og analoge forbindelser for behandling av fedme og diabetes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |